Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education. Faculty of Life Sciences, Northwest University, 229 Taibai North Road, Xi'an 710069, China.
School of Basic Medicine, The Fourth Military Medical University, 169 Changle West Road, Xi'an 710032, China.
Theranostics. 2019 Jan 1;9(2):466-476. doi: 10.7150/thno.29130. eCollection 2019.
The peroxisome proliferator-activated receptor γ (PPARγ) coactivator-1α (PGC-1α) was first identified in 1998 as a PGC-1 family member that regulates adaptive thermogenesis and mitochondrial function following cold exposure in brown adipose tissue. The PGC-1 family has drawn widespread attention over the past two decades as the energetic regulator. We recently summarized a review regarding PGC-1 signaling pathway and its mechanisms in cardiac metabolism. In this review, we elaborate upon the PGC-1 signaling network and highlight the recent progress of its versatile roles in cardiac diseases, including myocardial hypertrophy, peripartum and diabetic cardiomyopathy, and heart failure. The information reviewed here may be useful in future studies, which may increase the potential of this energetic regulator as a therapeutic target.
过氧化物酶体增殖物激活受体 γ(PPARγ)共激活因子-1α(PGC-1α)于 1998 年首次被鉴定为 PGC-1 家族成员,它可调节棕色脂肪组织在冷暴露下的适应性产热和线粒体功能。在过去的二十年中,PGC-1 家族作为能量调节剂受到了广泛关注。我们最近总结了一篇关于 PGC-1 信号通路及其在心脏代谢中的机制的综述。在这篇综述中,我们详细阐述了 PGC-1 信号网络,并强调了其在心脏疾病中的多种作用的最新进展,包括心肌肥大、围产期和糖尿病心肌病以及心力衰竭。这里综述的信息可能对未来的研究有用,这可能会增加这种能量调节剂作为治疗靶点的潜力。